MEMBERS AREA

 

 

Bonjour

 

 

Upcoming meetings

 

____________________________

05 avril 2018 –  réunion WP2 

06 avril 2018 –  rapport annuel scientifique et financier -ANR

19 avril 2018 –  réunion WP5 

Etat d’avancement

 

WP2 – New functions of PCSK9

 

  • Task 1 – PCSK9 and intestine 75%
  • Task 2 – PCSK9 and Lp(a) 100%
  • Task 3 – PCSK9 and diabetes 100%
  • Task 4 – PCSK9 and iPSC 51%

 

WP4 – Assessing the long-term safety of low LDL-C levels

 

  • Task 1 – Phenotyping of FHBL patients 16%
  • Task 2 – Assessing the prevalence of FHBL in a sychiatric population – PARTITION 37%

 

WP3 – Novel CV markers and protecting factors in FH

 

  • Task 1 – SAFIR study 50%
  • Task 2 – Genetics of CV protection in FH 20%
  • Task 3 – Biomarkers of CV protection in FH 23%
  • Task 4 – Validate new drug targets in CV protection 0%

 

WP5 – A genetically-based strategy to identify new targets in LDL-C metabolism

 

  • Task 1 – HYPOCHOL study 30%
  • Task 2 – Identifying new genes in FHBL and FH 25%
  • Task 3 – Functional characterization of new genes in FHBL and FH 40%